
Opinion|Videos|March 18, 2024
Pharmacist Role in Addressing Operational Challenges of Bispecifics in MM
Michael Singel, PharmD, discusses the role of pharmacists in the operationalization of bispecifics to treat multiple myeloma, including the creation of treatment plans and standard of care order sets.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Men Face Higher Odds of Later-Stage Diagnosis Across 20 Cancer Types
2
Investigational mRNA Flu Vaccine Broadens Antibody Defenses, Sustains Immune "Training Hub" Longer Than Standard Shot
3
FDA Accepts NDA for AD109 to Treat of Adults With Obstructive Sleep Apnea
4
FDA Approves Enlicitide, the First Oral PCSK9 Inhibitor for High Cholesterol
5







































































































